Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion type Assertion NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_head.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion description "[Treatment of human glioma A172 cells with 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethy-3-nitrosourea (ACNU) for 2 to 4 hr resulted in a 2- to 3-fold increase in steady-state levels of multidrug resistance-associated protein (MRP) and gamma-glutamylcysteine synthetase (gamma-GCS) mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_provenance.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion evidence source_evidence_literature NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_provenance.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion SIO_000772 9345268 NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_provenance.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion wasDerivedFrom befree-20150227 NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_provenance.
- NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_assertion wasGeneratedBy ECO_0000203 NP802340.RAXhI4-TRnHV1LojVbYDSFIjLVQWwH_AHPTgaGDY1IJcw130_provenance.